{"podcast":{"title":"The Fellow on Call: The Heme/Onc Podcast","slug":"the-fellow-on-call-the-heme-onc-podcast-4669989","podcast_index_feed_id":4669989,"rss_url":"https://www.thefellowoncall.com/tfocpodcast?format=rss","website_url":"https://www.thefellowoncall.com/tfocpodcast/","image_url":"https://images.squarespace-cdn.com/content/v1/61b273ac9be6aa2250498c9e/1641065434990-8BV6L7UFJF4JCCKCY6S1/Untitled+design+%281%29+copy.png?format=1500w","author":"Ronak Mistry","episode_count":164,"summary":"We quickly realized we knew very little about hematology and oncology when we started fellowship. Our goal is to bring you the fundamentals, core concepts and important management approaches in our field, driven by the latest evidence and expert opinion. In each episode, we will provide bite-sized, simplified approaches to common questions in a way that is perfect for anyone interested in hematology and oncology, from students and trainees to advanced practice providers and practicing physicians.","last_synced_at":"2026-06-24T18:17:58.817010+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989"},"episode":{"title":"Episode 138: Follicular Lymphoma Series, Pt 3 - Relapsed/Refractory Management (non-cellular therapy options)","slug":"episode-138-follicular-lymphoma-series-pt-3-relapsed-refractory-management-non-cellular-therapy-options","published_at":"2025-09-10T08:00:00+00:00","page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-138-follicular-lymphoma-series-pt-3-relapsed-refractory-management-non-cellular-therapy-options","show_page_url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989","url":"https://www.thefellowoncall.com/tfocpodcast/follicularrelapsedrefractory1","audio_url":"https://static1.squarespace.com/static/61b273ac9be6aa2250498c9e/t/68c057a791b42b54375b33d0/1758053073979/The+Fellow+On+Call+-+Follicular+Lymphoma+RR+-+Mix_FINAL.mp3","summary":"This week, we shift our focus to talking about relapsed/refractory follicular lymphoma. In this episode, we will specifically discuss treatment options other than cellular therapy, which will be an upcoming episode. If you have not done so, we highly recommend listening to part 1 and part 2 of this follicular lymphoma series so that you can better follow this week’s conversation! Episode contents: - What is the role of rituximab maintenance therapy? - What does surveillance after therapy look like? - What are options for treatment of patients who have relapsed follicular lymphoma? ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Google Podcast","meta_description":"This week, we shift our focus to talking about relapsed/refractory follicular lymphoma. In this episode, we will specifically discuss treatment options ot…","key_points":[],"chapters":[],"topics":[],"duration_seconds":null,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-fellow-on-call-the-heme-onc-podcast-4669989/episodes/episode-138-follicular-lymphoma-series-pt-3-relapsed-refractory-management-non-cellular-therapy-options/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-fellow-on-call-the-heme-onc-podcast-4669989/episode-138-follicular-lymphoma-series-pt-3-relapsed-refractory-management-non-cellular-therapy-options.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}